News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Slideshows|December 30, 2020

Looking Back: A Year in Review

Author(s)John J. Miller, MD

Take a look back at the year in covers with Psychiatric Times.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

time

The Element of Time in Psychotherapy

ByGerald P. Perman, MD

January 21st 2026

violence against doctor

Violence in Psychiatry: Stop Pretending It’s Just “Part of the Job”

ByGarrett Rossi, MD

January 20th 2026

diet eating disorder

Eating Disorders and Athletes: Why Awareness Matters

ByKaterina Paraskevas, MD, MPH,Mena Mirhom, MD, FAPA

January 19th 2026

suicide

I Wanted to Die. Now, I Help Others Choose Life.

ByDiana Guzman, LMHC-QS, MCAP, CCTP, CCATP

January 15th 2026

lonely

Should Solitude Be a Psychiatric Value?

ByRonald W. Pies, MD

October 23rd 2025

Latest CME

Optimizing Care for Patients With Tardive Dyskinesia

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Trending on Psychiatric Times

Exiting Antidepressants: A Needed Spotlight on Withdrawal

Combatting the Opioid Crisis With Evidence-Based Treatments

A Digital Therapeutic (CT-152) as Adjunct To Antidepressant Medication: A Phase 3 Randomized Controlled Trial (the Mirai study)

“If I Had Legs I’d Kick You”: Maternal Mental Health, Stress, and Risk

NDA Accepted and Priority Review Granted: Oveporexton for Narcolepsy Type 1